Michael Häggman
Director/Board Member bei PROSTATYPE GENOMICS AB
Profil
Michael Häggman currently works at Chundsell Medicals AB, as Director, Kardinaltalet AB, as Deputy Director, Prostatype Genomics AB, as Independent Director from 2018, Uppsala University Hospital, as Associate Professor-Urology, and Skrotum Kommanditbolag, as General Partner.
Aktive Positionen von Michael Häggman
| Unternehmen | Position | Beginn |
|---|---|---|
| PROSTATYPE GENOMICS AB | Director/Board Member | 01.01.2018 |
Chundsell Medicals AB
 Chundsell Medicals AB BiotechnologyHealth Technology Chundsell Medicals AB develops and markets novel molecular diagnostics for the treatment of cancer. Its product measures the expression pattern of selected embryonic stem cell genes in prostate cancer core needle biopsies. The company was founded by Sunne Rosell and Chunde Li in 2007 and is headquartered in Solna, Sweden. | Director/Board Member | - |
Kardinaltalet AB
 Kardinaltalet AB Miscellaneous Commercial ServicesCommercial Services Kardinaltalet AB provides business management consulting services. The private company is based in Stockholm, Sweden. | Corporate Officer/Principal | - |
| Skrotum Kommanditbolag | Corporate Officer/Principal | - |
Uppsala University Hospital
 Uppsala University Hospital Hospital/Nursing ManagementHealth Services Uppsala University Hospital operates a hospital. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PROSTATYPE GENOMICS AB | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Uppsala University Hospital
Uppsala University Hospital Hospital/Nursing ManagementHealth Services Uppsala University Hospital operates a hospital. | Health Services |
Chundsell Medicals AB
Chundsell Medicals AB BiotechnologyHealth Technology Chundsell Medicals AB develops and markets novel molecular diagnostics for the treatment of cancer. Its product measures the expression pattern of selected embryonic stem cell genes in prostate cancer core needle biopsies. The company was founded by Sunne Rosell and Chunde Li in 2007 and is headquartered in Solna, Sweden. | Health Technology |
Kardinaltalet AB
Kardinaltalet AB Miscellaneous Commercial ServicesCommercial Services Kardinaltalet AB provides business management consulting services. The private company is based in Stockholm, Sweden. | Commercial Services |
| Skrotum Kommanditbolag |
